Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2011-03-22
2011-03-22
Bristol, Lynn (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
07910696
ABSTRACT:
The invention describes HLA class II binding peptides encoded by the SSX-2 tumor associated gene, as well as nucleic acids encoding such peptides and antibodies relating thereto. The peptides stimulate the activity and proliferation of CD4+T lymphocytes. Methods and products also are provided for diagnosing and treating conditions characterized by expression of the SSX-2 gene.
REFERENCES:
patent: 5840839 (1998-11-01), Wang et al.
patent: 6548064 (2003-04-01), Tureci et al.
patent: WO 9602641 (1996-02-01), None
patent: WO 00/00642 (2000-01-01), None
patent: WO 01/23560 (2001-04-01), None
patent: WO 01/82963 (2001-11-01), None
WO 9602641 (Cooper et al. Feb. 1996) sequence search alignments for SEQ ID Nos.:1-8.
WO 2003008537 (Simard et al. Jan. 2003) sequence search alignments for SEQ ID Nos.:1-8.
Bowie et al. (Science. Mar. 19, 1990; 247 (4948): 1306-1310).
Schirle et al. (J. Immunol. Methods. 2001; 257: 1-16).
Sanderson et al. (PNAS 92:7217-7221 (1995).
Arnold et al. (J. Immunol. Methods 271: 137-151, 2002).
Ayyoub, Maha et al., “Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells,”Journal of Immunology2004; 172(11): 7206-7211.
Ayyoub, Maha et al., “Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma,”Journal of Immunology2002; 168(4): 1717-1722.
Wagner, Claudia et al., “Identification of HLA-A*0201 binding antigenic peptides derived from the HOM-MEL-40/SSX-2 antigen that stimulate CTL from patients with SSX-2 positive cancers,” Proceedings of the American Association for Cancer Research Annual Meeting; Mar. 2002; vol. 43, p. 606.
Ayyoub Maha
Valmori Danila
Bristol Lynn
Ludwig Institute for Cancer Research Ltd.
Wolf Greenfield & Sacks P.C.
LandOfFree
Ssx-2 peptides presented by hla class II molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ssx-2 peptides presented by hla class II molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ssx-2 peptides presented by hla class II molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2747730